Skip to content
HowShorted

Replimune Group, Inc. short interest in 2025

In 2025, Replimune Group, Inc.'s disclosed short interest ran from 10.61% of shares outstanding on 15 Jan 2025 to 17.06% on 31 Dec 2025, a change of +6.45 percentage points. The year's high was 24.59% on 15 Aug 2025 and its low 10.41% on 15 Jul 2025, averaging 15.97% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.32 days on 14 Mar 2025. Full history: Replimune Group, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Replimune Group, Inc. in 2025

2025 in figures

Start of year
10.61% (15 Jan 2025)
End of year
17.06% (31 Dec 2025)
Change
+6.45 pp
High
24.59% (15 Aug 2025)
Low
10.41% (15 Jul 2025)
Average
15.97%
Highest days to cover
16.32 (14 Mar 2025)
SEC filings marked
8

Every report in 2025

Replimune Group, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202510.61%9.83
31 Jan 202512.38%8.91
14 Feb 202511.79%16.1810-Q filed, results (8-K)
28 Feb 202511.87%14.37
14 Mar 202512.40%16.32
31 Mar 202512.43%12.27
15 Apr 202511.46%8.34
30 Apr 202511.91%10.68
15 May 202511.97%7.49
30 May 202511.05%4.6310-K filed, results (8-K)
13 Jun 202512.11%7.84
30 Jun 202512.85%8.60
15 Jul 202510.41%3.94
15 Aug 202524.59%2.6310-Q filed, results (8-K)
29 Aug 202523.79%9.74
15 Sep 202522.13%7.06
30 Sep 202522.91%2.68
15 Oct 202523.38%6.24
31 Oct 202520.63%1.30
14 Nov 202521.29%6.0410-Q filed, results (8-K)
28 Nov 202519.47%9.90
15 Dec 202518.82%7.97
31 Dec 202517.06%10.64

See also: Replimune Group, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.